FROM THE FOUNDATIONBritish philosopher and writer Bertrand Russell said, “To conquer fear is the beginning of wisdom.” But how do we conquer something as challenging as cancer? At the Conquer Cancer Foundation (CCF) of the American Society of Clinical Oncology (ASCO), we believe the best way to remove the worries of treating and surviving disease is by outsmarting it. With your support, we are doing this by investing in the brightest minds in cancer research. When it comes to conquering cancer, we must salute and honor the Conqueror in All of Us, including:

• Patients and families who receive cancer diagnoses to find they must rallyagainst this disease;

• Researchers who surmount scientific challenges to identify new discoveries;

• Physicians who advance new treatments and share data to help others; and

• Donors who fund the work that fuels additional innovation and tangible results.

Sometimes, these roles overlap in unimaginable ways. In this year’s annual report, we introduce you to Dr. Dustin Deming, a colorectal cancer researcherdiagnosed with the exact disease he studies only one year after receiving a CCF Young Investigator Award (YIA). Among other factors, he found greater wisdom and empathy from his aggregated role of investigator, doctor, and patient.

In 2016, CCF can point to distinct achievements that helped us fulfill our mission to conquer cancer worldwide by funding breakthrough research and sharing cutting-edge knowledge. First, through your generous financial support, we awarded 339 grants and awards to researchers and research institutions to advance cancer discoveries around the world.

Additionally, 2016 marked continued support of CancerLinQ®, ASCO’s health infor-mation technology platform and Cancer.Net, ASCO’s patient information site, which brings the expertise and resources of ASCO to patients and caregivers everywhere.

We are proud to note that in 2016 CCF maintained a four-star rating –the highest available – from Charity Navigator, the nation’s largest independent evaluator of non-profit organizations. Our four-star rating communicates to current and prospective donors that we are using your funds to achieve our goals effectively, efficiently, and ethically. Likewise, CCF received the highly coveted accredited charity designation from Give.Org Charity Review, produced by the BBB Wise Giving Alliance.

Returning to Bertrand Russell, his use of the word Conquer in the context of overcoming fear continues to resonate. As a pacifist, he was not invoking a military battle but instead an inner strength built on knowledge, confidence and hope. We thank you, our dedicated donors and supporters, for helping usincrease knowledge, raise confidence, and instill hope that moves us closer to a world free from the fear of cancer. As we conquer cancer, your continued generosity is everything and we thank you for it.

Sincerely, Thomas G. Roberts, Jr., MD chair

Clifford A. Hudis, MD, FACP, FASCO chief executive officer

Nancy R. Daly, MS, MPH executive vice president & chief philanthropic officer

2016 BOARD OF DIRECTORSThomas G. Roberts, Jr., MD chair

Clifford Hudis, MD, FACP, FASCOceo, ex-officio

Allen Lichter, MD, FASCO ceo, ex-officio (october 8, 2006–june 30, 2016)

Sandra M. Swain, MD, FACP, FASCOtreasurer

Claire A. Huangsecretary

Daniel F. Hayes, MD, FACP, FASCOasco president, ex-officio (june 6, 2016–june 5, 2017)

Julie Vose, MD, MBA, FASCO asco president, ex-officio (june 1, 2015–june 6, 2016)

Nancy R. Daly, MS, MPH executive vice president andchief philanthropic officer, ex-officio

Alexander W. CasdinLawrence H. Einhorn, MD, FASCOJohn H. Glick, MD, FASCO, MACPMichael Gordon, JDGabriel N. Hortobagyi, MD, FACP, FASCORaj Mantena RPhThomas A. Marsland, MD, FASCORobert J. Mayer, MD, FASCOW. Charles Penley, MD, FASCOchair emeritus

Steven T. Rosen, MD, FACPAaron A. SassonMargaret A. Tempero, MD, FASCO

FINANCIAL REVIEWYou contributed more than $23M to fund breakthrough research and share cutting-edge knowledge.

REVENUESCorporate 12,852,081

Foundation 8,393,684

Individual 1,913,078

TOTAL REVENUES 23,158,843

EXPENSESPrograms 22,485,135

Fundraising 4,314,097

Administration 291,843

TOTAL EXPENSES 27,091,075

Operating Deficit –3,932,232

Long Term Investment 1,559,868

Change in Net Assets –2,372,364

> Change in Unrestricted Net Assets 2,141,362

> Change in Restricted Net Assets –4,513,726

Unrestricted Net Assets Beginning of Year 28,196,097

Restricted Net Assets Beginning of Year 29,695,728

Unrestricted Net Assets End of Year 30,337,459

Restricted Net Assets End of Year 25,182,002

VALIDATING EFFICIENCY

In 2016, The Conquer Cancer Foundation pursued third-party reviews relative to the stewardship of your vital donations via Give.Org, the Better Business Bureau’s Wise Giving Alliance, and Charity Navigator, the nation’s largest independent evaluator of non-profit organizations. Using more than 20 different metrics, both groups assess and confirm qualities such as fair governance, positive program results, financial accountability and overall transparency. These examinations communicate to current and prospective donors that we are using your generous donations to achieve our goals effectively, efficiently, and ethically.

Charity Navigator: 4 out of 4 starsGive.Org (BBB): Fully-Accredited

4-S

TAR

RA

TIN

G IN

20

16 O

N C

HA

RIT

Y N

AV

IGA

TO

R

TH

E C

ON

QU

ER

OR

IN

AL

L O

F U

S

On a very unlucky Friday the 13th in July 2012, Dr. Dustin Deming, working in the dual role of gastrointestinal oncology researcher and physician, suddenly took on a third one: patient. Diagnostic irony rang out when he learned it was colorectal cancer. The news came just one year after he received a Conquer Cancer Foundation (CCF) of ASCO Young Investigator Award (YIA) to study the disease.

As researcher, Dr. Deming develops mouse models that reflect the tumor biology of current patients, facilitating rapid treatment protocols. As patient, he hopes to remain free of disease to and beyond the five year mark. As physician, relationships with patients now involve a deeper dimension than before his diagnosis.

Dr. Deming’s treatment for stage 3c colorectal cancer included a cycle of chemotherapy, radiation, surgery, and more chemo. Throughout the process, he continued to work in the lab and to see his patients.

“At some point, it made sense to share my experience. It has yielded huge rewards, professionally and personally,” Dr. Deming added. “One day, a

patient inquired about the mechanics of a chest port. Something clicked, and I just pulled my lab coat and shirt aside and said, ‘This is what it looks like. This is what it feels like. And this is how I feel about it. The physician-patient relationship is forever changed in that moment.”

Still, the fluid nature of Dr. Deming’s three roles has boundaries.

Dr. Deming notes, “when I’m giving a lecture, it’s about the science, not about me. But it really comes back to my desire to feel normal. A diagnosis can be a label that’s impossible to shake.”

Research labs are filled with labels. A single mark defines the spot where a clinical trial moves forward versus one that ends for inefficacy or lack of funding. For Dr. Deming, either result creates urgency.

“I see patients with a specific tumor biology and return to the lab to develop treatment protocols with drug combinations we can use quickly. I value passionate researchers who focus on a specific path for decades, no matter how many times they hit

a wall. Their persistence yields brilliance. By contrast, if something in my lab can’t progress to a clinical trial, we move on to something that can. As a patient – and through my relationship with patients – I seethe need for better treatments daily and I’m compelled to act.”

As a donor, you are also compelled to act. Your generosity absorbs the weight of diagnosis for patients, enhances the quality of care physicians can provide, and enables the brightest minds in cancer research to stay in their labs exploring new ways to improve treatments for all types of cancers.

The Conquer Cancer Foundation is grateful for the generous donors that help fund breakthrough research like Dr. Deming’s, whose early work revealed a new subtype of colon cancer. Your dollars accelerate our ability to share cutting-edge knowledge globally, resulting in new, life-changing discoveries and treatments to conquer cancer and to improve quality of care. Dr. Deming is a conqueror.

And, there is a conqueror in you.

THE CONQUEROR IN DR. DUSTIN DEMING

CO

NQ

UE

R.O

RG

THANK YOU

The Conquer Cancer Foundation of ASCO salutes

the generous involvement of donors whose increased

financial support enabled the significant progress

made this year.

Whether donor, researcher, physician, patient, or some

combination of these roles, mobilizing the Conqueror in

All of Us through teamwork and professional development

remains the best way to advance breakthrough research

and improved care. Nearly 1.8 million people in the US

were diagnosed with cancer in 2016 and, internationally,

19.5 million cases will be identified annually by 2025.

Sources:

(1) https://www.cancer.gov/about-cancer/understanding/statistics

(2) https://www.cdc.gov/cancer/international/statistics.htm

ADVANCING RESEARCH

At CCF’s core is the desire to forward research initiatives that originate from the brightest minds in cancer research. Your generous contributions in 2016 allowed investigators around the world to study subjects as diverse as:• Assessing treatment preferences and goals for older

adults with cancer;• Preventing, detecting and treating a rare form of

bile duct cancer;• Examining melanoma cell mutation resistance; and• Developing new immunotherapies for leukemia.

The Campaign to Conquer Cancer

May 2015 LaunchDecember 2016$139M Goal$150M

Grants & Awards

339 Total

Young Investigator Awards (YIA)

58 Total

BUILDING ON KNOWLEDGE

For Professionals — Amidst record-setting attendance, ASCO’s Annual Meeting welcomed former Vice President Joe Biden who urged conference-goers to provide bold ideas to advance the nation’s Cancer Moonshot Initiative.

An additional five symposia throughout 2016 offered interactive educational opportunities for more than 8,000 participants dedicated to cancer survivorship, quality and palliative care, and genitourinary and gastrointestinal cancers.

For Patients and Families — With the launch of an accessibility initiative to increase functionality for people with disabilities, Cancer.Net continued to provide valuable, vetted, and up-to-date cancer information. Your philanthropic gifts resulted in a banner year for Cancer.Net: the information ecosystem received 11 awards for its overall utility, blog, podcasts and mobile app, including a Gold Award for Best Healthcare Content from the eHealthcare Leadership Awards.

Patient Records

1M+ → 1.5M+Oncology Practices

20 → 78(+190%)

Annual MeetingAttendance

28K → 32K

From

(2015 → 2016)

Cancer.Net Site Traffic

25% →

CHAMPIONING DISCOVERY: BIG DATA

For Physicians and Researchers —

With thoughtful donor support, CCF continues

to build and to promote CancerLinQ®, a real-time

electronic health records platform whose data

provides physicians with immediate insights

about effective treatment protocols

and patient care.

Conquer Cancer Foundation

@ConquerCancerFD

conquercancerfoundation

FUNDING WOMEN IN SCIENCE

Women Who Conquer Cancer (WWCC) promotes female leadership in oncology research and assists early-career women physicians transitioning from their final years of training into new faculty appointments. Your financial gifts enabled women-led networking and career support initiatives throughout 2016.

Celebrating Female MentorshipSarah S. Donaldson, MD, FASCO received the inaugural WWCC Mentorship Award in 2016. As the first female president of multiple national medical societies and a leading pediatric oncology researcher and patient care advocate, colleagues cite Dr. Donaldson’s defining career achievement as her steadfast mentorship.

Continue efforts to raise

$1.35M toward endowing a WWCC Young Investigator Award

WWWC Young Investigator Awards

1 → 3recipients

IDEA Nations

17

International Development and Education Award (IDEA)IDEA Awards

23

Long-term International Fellowship (LIFe)

Awards

4 Nations:Mexico, Brazil, China and Jordan

Countries Represented at ASCO Annual Meeting

125 → 149

GLOBAL ONCOLOGY

To fulfill the reach of its mission to conquer cancer

worldwide, CCF invests in grants dedicated to research

around the globe and patients in low and middle-income

countries.

International Guests – 55% of total Cancer.Net traffic

CHAMPIONS Champions are donors who have given $1,000,000 or more cumulatively in their lifetime. Anonymous

American Society of Clinical Oncology

Amgen

Astellas

AstraZeneca

Avon Foundation for Women

Bayer HealthCare Pharmaceuticals Inc.

Boehringer Ingelheim Pharmaceuticals, Inc.

Breast Cancer Research Foundation®

Bristol-Myers Squibb

Cancer Treatment Centers of America®

Celgene Corporation

Dendreon Corporation

Eisai Inc.

EMD Serono Inc.

Genentech BioOncology™

GlaxoSmithKline Oncology

Gordon Family Foundation

HELSINN

Incyte Corporation

Integra Connect

Janssen Oncology

Lilly

LIVESTRONG Foundation

Raj Mantena, RPh

Merck & Co., Inc.

Novartis Oncology

Pfizer Oncology

Physicians Education Resource

Roche

Sanofi Genzyme

Sarcoma Foundation of America

Aaron and Barbro Sasson

Susan G. Komen®

Takeda Oncology

Teva Oncology

S U P P O R T E R AC K N OW L E D G M E N TThe Conquer Cancer Foundation gratefully acknowledges the individuals and organizations whose

2016 donations are funding breakthrough cancer research and sharing cutting-edge knowledge through The Campaign to Conquer Cancer. Visit CONQUER.ORG to make your 2017 gift.

T H E C O N Q U E R O R I N A L L O F U S

The Conquer Cancer Foundation gratefully recognizes members of the Conquerors Circle who made gifts of $1,000 or more in 2016. Anonymous

Farrukh M. Adhami, MD

Alex A. Adjei, MD, PhD

David Adler

Cathleen Ahearn

Paul Aines

Christina M. Annunziata, MD, PhD

Carol Appel

Jeff and Rebecca Atkinson

Kara Bachman

Joseph S. Bailes, MD, and Yvonne S. Bailes

Ed Balaban

Charles M. Balch, MD, FACS, FASCO, and Carol Balch

Lodovico Balducci, MD

Tarit Kumar Banerjee, MD

Adrian Barfield

Brigitte Barrette, MD

Teresa Bartels

Robert C. Bast, MD, and Blanche S. Bast

Rosemarie Bastone

Susan E. Bates, MD

Tanios S. Bekaii-Saab, MD, FACP

Diana Benson

Monica M. Bertagnolli, MD, and Alexander H. Dannenberg, PhD

Smita and Ravi Bhatia

Nirmala Bhoopalam, MD

Charles D. Blanke, MD, FASCO

Dr. and Mrs. Douglas W. Blayney

Clara D. Bloomfield, MD, FASCO

George J. Bosl, MD, FASCO

Dr. Linda D. Bosserman and Hon. Theodore Piatt

Riccardo Braglia

Hon. Nancy G. Brinker

Susan Brousseau

Paul A. Bunn, Jr., MD, FASCO

Howard A. Burris, III, MD, and Karen Y. Burris

Dr. David Bush

Nicola Bush

Pablo J. Cagnoni, MD

Alejandro R. Calvo, MD

Ila Campbell

Ana Canal and Emilio Canal, Jr., DDS

Michael and Kathy Carducci

Alexander and Susan Casdin

Robert and Katherine Ceremsak

Kuo Chao

Dr. Anita Chawla

Kwai Chow

Neal Paul Christiansen, MD, FACP

Erik Chu

Marc L. Citron, MD

Susan Clare

Glenda Claremon

Bayard Clarkson, MD, BSN, OCN, FASCO

Gary I. Cohen, MD, FASCO, and Charlene M. Cohen

Harvey J. Cohen, MD, and Mrs. Sandra L. Cohen

Susan Lerner Cohn, MD

Terry Coleman

Charles L. Conlon, MD

Lisa Conte

Bob Cox

John V. Cox

Walter J. Curran, Jr., MD, FACR

Violante E. Currie, MD

Anthony Cutrone

Nancy R. Daly, MS, MPH

Chau T. Dang, MD

Nancy E. Davidson, MD, FASCO

Peter Davis

Joseph Deegan-Day

Neelima Denduluri, MD

Julie Dexter

Michael Diaz, MD

Adam and Adrien Dickerson

Gary C. Doolittle, MD

Dana L. Dornsife

Carol D. Doyle-Clarke

James Early

Martin J. Edelman, MD

Stephen B. Edge, MD, FASCO

Lawrence H. Einhorn, MD, FASCO, and Claudette Einhorn

Ira and Roni Elegant

David S. Ettinger, MD

Fleur E. Fairman

Caroline Fales

Stuart P. Feldman, MD

Lisa Fichtel, MD

Margaret Fletcher

Thomas Folchi

James M. Ford, MD

Jill M. Forrest

Dr. Paula M. Fracasso and Mr. John S. Francis

Dr. James and Leslie Frame

Loraine and Bert Fulmer

Gwen A. Fyfe, MD

Patricia A. Ganz, MD, FASCO

Maria Garcia, MD

Elaina M. Gartner, MD

Alfred R. Gaudelli

John A. Gentile, Jr., BSc, RPh

Thomas J. George, Jr., MD, FACP

Phyllis Ghio

Timothy D. Gilligan, MD, MSc

Julia Lynne Glade Bender, MD

John H. Glick, MD, FASCO

Jose Luis Gonzalez

Bobby L. Graham, MD

Bart and Alice Grantham

Bradley Grantham

Sybil R. Green, JD, MHA, RPh

Jean L. Grem, MD

Stephen S. Grubbs, MD

Dr. Missak Haigentz and Mrs. Madaline Haigentz

Roger Halualani

John and Jessie Hart

Cheryl A. Harth, MD

Lawrence Haskell

Daniel and Jane Hayes

Charles A. Henderson, MD

Carolyn B. Hendricks, MD

Betty Hinds

Adam and Denise Hoeflich

Paulo M. Hoff, MD, FACP

Sandra J. Horning, MD

Bob and Jeanne Hsia

Claire Huang and Mark Wildermuth

Clifford A. Hudis, MD

Melissa M. Hudson, MD, and Albert E. Weeks, MD

Erin Hultman

Melinda and James Hurley

Arti Hurria, MD

Maha Hussain, MD, FASCO

Sarah G. Hymowitz, PhD

Lowell F. Inhorn, MD, and Cynthia Petzold

Yassamin and Farid Jalinous

Linda Jensen

Bruce E. Johnson, MD, and Georgia Johnson

Deborah Y. Kamin, PhD

Beth Y. Karlan, MD

Nina J. Karlin, MD, FACP

Suresh B. Katakkar, MD

Jeffrey and Marnie Kaufman

Alan M. Keller, MD

Michael J. Kelley, MD

Jack Kennedy

Edward S. Kim, MD

Jeffrey J. Kirshner, MD

Kimberley Klingler

Feng Ming Kong, MD

Michael P. Kosty, MD, FACP, FASCO

Miodrag Kukrika, MD

Kathleen Lada

Esther Lam

Josh David Lauring, MD, PhD

Ronald L. Lay

Matt Lee

William T. Leslie, MD

Barbara and John Lewis

Michael Paul Link, MD, FASCO

John Lombardi

Phil and Kathey Longorio

Katherine Y. Look, MD

Jennifer A. Low, MD, PhD

Karen H. Lu, MD

Christine Luckscheiter

Drs. Gary H. Lyman and Nicole M. Kuderer

Conor Lynch

Ronald John Maggiore, MD

Phillip Manning

Raj Mantena, RPh

Benjamin T. Marchello, MD, and Mary Lou Marchello

David A. Margileth, MD

Kim Allyson Margolin, MD

Musa and Thomas Mayer

Robert J. Mayer, MD, FASCO

Jodi McDermott

William P. McGuire, MD

David R. Melin

Honor Mello

Robert G. Mennel, MD, FASCO

Drs. Sharon and Neal Meropol

Dina L. Michels, Esq., and Peter Engel

Ryan A. Milburn

Robert S. Miller, MD, FACP, FASCO, and Dorothy Miller

I. Monica Minkoff, MD, and Harry Siegfried

MJ Moltenbrey

Victoria Montgomery

Anne Moore, MD

Robert Morgan, MD

Joanne E. Mortimer, MD

Julie Mosley

Therese M. Mulvey, MD, FASCO

Hyman and Loretta Muss Family Fund

Craig R. Nichols, MD

NF Nimeh, MD

Oleg Nodelman

Dr. Luke and Rachel Nordquist

Susan M. O’Brien, MD

Kevin and Lori O’Connor

Faith D. Ottery, MD, PhD

Ann Paradise

Nayan G. Parekh, PhD

Susan Parsons, MD, and Walter G. Armstrong

Debra Patt MD, Texas Oncology

W. Charles Penley, MD, FASCO, and Connally Penley

Francine Pepitone

Richard Petit

Jennifer Perry, PharmD

Lori J. Pierce, MD, FASCO

Phyllis Pohl

Joseph D. Purvis, MD

Derek Raghavan, MD, PhD, FACP, FASCO

Susan and Kanti Rai

Kimryn Rathmell, MD, PhD

Deana and James Ratto

Pamela and Charles Reardon

M. Michele Redden-Borowski, MD

Robert M. Rifkin, MD

Thomas G. Roberts, Jr., MD, and Susan M. DaSilva

Anne Marie Robertson

Gabrielle Rocque

Gladys I. Rodriguez, MD

Lisa Rodriguez

Angel M. Roman-Diaz, MD

Steven T. Rosen, MD, FACP, and Candice Rosen

Mace and Joyce Rothenberg

Melanie Royce, MD, PhD

Debasish and Suraja Roychowdhury

Carolyn D. Runowicz

Roger and Vicki Sant

Aaron and Barbro Sasson

Richard L. Schilsky, MD, and Cynthia S. Schilsky

Lynn Mara Schuchter, MD, FASCO

Scott Schuetze, MD, PhD

Steven and Gail Shak

Sandra Shaw

Steven Sheck

Frances A. Shepherd, MD

Stephen A. Sherwin, MD

Rachna T. Shroff, MD

Robert D. Siegel, MD

William M. Sikov, MD, FACP

Mr. Jackson G. Simpson

David C. Smith, MD

Eileen P. Smith, MD

Michael L. Smith

David R. Spriggs, MD

Robert J. Stagg, PharmD

Jed Steele

Cora N. Sternberg, MD

James A. Stewart, MD

Mary L. Stewart, MD

Anna M. Storniolo, MD

Joseph Sum

Bob and Bobbie Sutton

Sandra M. Swain, MD, FACP, FASCO, and Steven Jones

Riaz Taplin

Richard Tempero, MD, and Margaret A. Tempero, MD

Marilou Terpenning, MD, FACP

Michael A. Thompson, MD, PhD, and Kelly M. Thompson

Lisa W. Tichenor

Shawn C. Tomasello

Elaine L. Towle

Michael B. Troner, MD, FASCO

Donald L. Trump, MD

William Tunno

Marianne A. Urry

Deanna van Gestel

Daniel and Ann Von Hoff

Jamie H. Von Roenn, MD, FASCO

Julie M. Vose, MD, MBA, FASCO

James L. Wade, MD, FASCO

Olivia Ware

David M. Waterhouse, MD, MPH

Kenneth and Andrea Weckstein

Mike White

Pamela Wilder

Eric P. Winer, MD, FASCO

Janice Wise

Jedd D. Wolchok, MD, PhD

Robert A. Wolff, MD

Sandra L. Wong, MD, MS

Yu-Ning Wong, MD

Antoinette J. Wozniak, MD

Mr. and Mrs. Robert S. Wu

Christopher Wynn

DeeAnn Yabusaki

William S. Yaus

William Yoon, PharmD

Robert C. Young, MD, FASCO

Ruth T. Young, MD, MA, MHA

Peter P. Yu, MD, FASCO

Sharon and Robert Zachte

Sara L. Zaknoen, MD

Marvin Zalesin

Dr. Robin Zon and Family

Alexander Zukiwski, MD

ORGANIZATIONS Anonymous

Abbey of Our Lady of the Holy Trinity

AbbVie, Inc.

ABIM Foundation

Abt SRBI

Academy of Managed Care Pharmacy

Accurate Development, Inc

Acuity Charitable Foundation, Inc.

Adenoid Cystic Carcinoma Research Foundation

Alabama Cancer Congress

AlphaMed Press

Amazon Smile Foundation

Ambry Genetics

American Cancer Society

American Endowment Foundation

American Legion Riders

American Society for Radiation Oncology

American Society of Clinical Oncology

Amgen

AMN Healthcare

ARIAD Pharmaceuticals, Inc.

The Arizona Clinical Oncology Society

Arthur E. McAlarney Trust

Ascend Federal Credit Union

Assabet Valley Federation of Teachers

Association of Northern California Oncologists

Astellas

AstraZeneca

AstraZeneca Healthcare Foundation

Bank of America Charitable Gift Fund

Barbara Eads Realty, Inc.

Baxalta Matching Gifts Program

Baxalta Incorporated

Bayer HealthCare Pharmaceuticals Inc.

BCCNS Life Support Network

Best Bay Apartments Inc.

Biogen

The Blanke Foundation, Bank of America, N.A., Trustee

Bloomingdale’s

Bluefish Cove Improvement Association

Boehringer Ingelheim Pharmaceuticals, Inc.

Breast Cancer Research Foundation®

Bright Newhouse Insurance

Bristol-Myers Squibb

Bristol-Myers Squibb Foundation

Brooks Brothers

CAE USA, Inc.

Cancer Treatment Centers of America®

Catalina Barber Corporation

Catania, Mahon, Milligram & Rider, PLLC

Celebrant USA Foundation Inc.

Celgene Corporation

Chicago Match Race Center

Cholla Foundation

Clean Solar, Inc.

Coalition of Cancer Cooperative Groups

Coherus BioSciences

Commonwealth of Massachusetts

The Community Foundation for Greater New Haven

Community Foundation of Greater Greensboro

The Community Foundation of Macon County

Cong. of New Square

Connecticut Oncology Association

Covance, Inc.

CRDF Global

CREATION

Crest Flooring

Daniel G. Martinelli Plumbing

Delta Council 44 Air Line Pilots Association

The Donald T. Regan Foundation

East Madison Quilt & Needlework Group

eBay Giving Works

Eisai Inc.

EMD Serono Inc.

Erie Insurance

Ethicon

Evolver, Inc.

Exelixis, Inc.

Ferring Pharmaceuticals,

Inc.

Fidelity Charitable Gift Fund Foundation Medicine Frontier Motel The Fuller Foundation Garcia Family Charitable FoundationGateway for Cancer ResearchGenentech BioOncology™ Genomic Health, Inc. Genpak, LLC Georg Jensen Georgia Society of Clinical Oncology

Gilead Sciences, Inc. Gordon Family Foundation

The Gorelick Family Revocable Trust

GT Management

Guardant Health, Inc.

Harborside Press

Harmelin & Associates, Inc.

Harnish Transportation, Inc.

Hawaii Society of Clinical Oncology

Hedgepeth Williams Middle School of the Arts

HELSINN

Hematology Oncology Managers of New York, Inc.

The Hera Foundation

Hewlett-Packard, Inc.

Hilton Chicago

Hollander Hambleton Family Trust

Hyatt

Hymowitz Family Foundation

Ibabao Realty, LLC

iGive.com

Illinois Medical Oncology Society

Illumina, Inc.

Inc Research, LLC

Incyte Corporation

Indiana Oncology Society

Industrial Aircraft Lodge No. 1746

Infinity Pharmaceuticals Inc.

Insearch Consulting LLC

Integra Connect

Interstate Casing Corporation

Ipsen Biopharmaceuticals Inc.

J. Edward Mahoney Foundation

Janssen Oncology

Japan Comprehensive Cancer Network, Breast

Jazz Pharmaceuticals

JCPenney

Jeanne V. Reed Charitable Foundation

The John and Elizabeth Leonard Family Foundation

Journal of Clinical Oncology

JP Morgan Chase

Foundation

JPS Services LLC/DBA Gem Services

JustGive.org

Kansas Society of Clinical Oncology

Kegonsa Hustlers 4-H Club

Kelly Cares Foundation

Kendra Scott

Kidney Cancer Association

L & M Plumbing and Heating

La Perla

Lawrence J. Epstein Living Trust

Leo H. Bendit Charitable Foundation

Letters & Sciences

Lighthouse Pointe

Lighthouse Sunday School Class

Lilly

Local Independent Charities of America

Lord and Taylor

Ludwig Cancer Research

Lung Cancer Alliance

Macy’s / Bloomingdale’s

The Maggie & Waggie Foundation, a Donor Advised Fund of Renaissance Charitable Foundation

Marchello Family Fund

Martin and Mary L. Boyer Foundation

Maryland/D.C. Society of Clinical Oncology

Massachusetts Medical Society

McGivney Global Advisors LLC.

MCM Education

MD Anderson Cancer Center

Medical Oncology Association of Southern California, Inc.

Medivation

Megabyte Licensing Corporation

The Melior Group, Inc.

Melody & Company, Inc.

Merck & Co., Inc.

Merrimack

Pharmaceuticals

Michael Price and Associates, LLC.

Michael’s Mission

Michiana Hematology Oncology

Michigan Society of Hematology and Oncology

Microsoft

Millennium Pharmaceuticals Matching Gift Program

Minnesota Society of Clinical Oncology

Missouri Oncology Society

Modern Luxury

Montana State Oncology Society

Morgan Stanley Smith Barney Global Impact Funding Trust, Inc

MSA Research, LLC.

Mt. Airy Mattress

My Tribute Gift Foundation, Inc.

Myriad Genetics, Inc.

Nancy Brinker Charitable Foundation

National Alliance of Postal and Federal Employees Local 410

National Cancer Institute

National Christian Foundation®

National Comprehensive Cancer Network

National Data Systems, LLC

Network For Good

Nevada Oncology Society

New Rhein Healthcare, LLC

The New York Community Trust

Nieman Charitable Foundation Inc.

North Carolina Oncology Association

North Coast Driving School

Northern New England Clinical Oncology Society

Northern Trust Charitable Giving Program at the Chicago Community Foundation

Novartis Oncology

Novocure

NY Intl ATC Hockey Team

Oregon Society of Medical Oncology

Parkway Wozniak Memorial Home, Inc.

Patient Access Network Foundation

Patient Alliances

Patient Resource LLC

Patricia Hyde Living Trust

PayPal Gives Employee Engagement Fund

Pennridge Central Middle School Microloans Club

Penske Truck Leasing

The Peter Daniel Seligman Foundation

Pfizer Foundation

Pfizer Oncology

Pharmacyclics LLC

Quantum Group

Raymond James Charitable Endowment Fund

RBR Partnership

Region Welding of Missouri

Renaissance Charitable Foundation, Inc.

Research Advocacy Network

Research To Practice

rEvolution Marketing LLC

The Richardson Family Revocable Living Trust

Roche

Rocky Mountain Oncology Society

Roland-Story High School National Honor Society

The Romano Family Private Foundation

RSG Investment Group, LLC.

Sacro Plaza Reading Room

Schwab Charitable Fund

Seattle Genetics

Senior Citizens Friendship Club

Six Stars Auto Sales, Inc.

Snyder Swimming Pools, Inc.

Sofitel Luxury Hotels

South Bend Medical

Foundation

Southfield Oncology Institute

St. John Knits

Star Nails

Stavros Niarchos Foundation

Steel City Bowling League

Strike 3 Foundation

Substance

Subway

Susan Frankl & George Demetri Charitable Foundation

Susan G. Komen®

TAIHO Oncology, Inc.

Takeda Oncology

Tennessee Oncology Practice Society

TESARO

Texas Society of Clinical Oncology

Thomas S. Brown Associates, Inc.

Tokai Pharmaceuticals, Inc.

Tory Burch

Tri-City Christian School

Trinity Lutheran School

Triple Negative Breast Cancer Foundation

TRUiST

United Way of Central New Mexico

United Way of the Columbia- Willamette

UnitedHealth Group

University of Colorado Health

Utah Hematology Oncology, P.C.

Vanguard Charitable Endowment Program

Virginia Association of Hematologists & Oncologists

W.M. Keck Foundation

Waldorf Astoria Chicago

Washington State Medical Oncology Society

The Waterloo Boys of Southeastern PA

Webster Properties

Wells Fargo Philanthropy Fund

West Virginia Oncology Society

Westerlin Flying Service, Inc.

White & Day Mortuaries

Willing Workers Sunday School Class, Poplar Ridge Christian Church

Wisconsin Association of Hematology and Oncology

The Wrightson Family Endowment Fund

The WWWW Foundation, Inc. (QuadW) and The Sarcoma Fund of the QuadW Foundation of Communities Foundation of Texas

YourCause, LLC Trustee for Chevron Matching Employee Funds

YourCause, LLC Trustee for PepsiCo Employee Giving Program

CANCERLINQ MAJOR SUPPORTERS AmgenAstellasAstraZenecaBayer HealthCare Pharmaceuticals Inc.Boehringer Ingelheim Pharmaceuticals, Inc.Cancer Treatment Centers of America®Chan Soon-Shiong Family FoundationGenentech BioOncology™HELSINNJanssen OncologyLillyRaj Mantena, RPhNovartis OncologyPfizer OncologyThomas G. Roberts, Jr., MD, and Susan M. DaSilvaSusan G. Komen®

MISSION ENDOWMENTFounding DonorsGenentech BioOncology™GlaxoSmithKline OncologyNovartis OncologySanofi Genzyme

Sustaining DonorsAbbVie, Inc.AmgenAstellasAstraZenecaCelgene CorporationEisai Inc.EMD Serono Inc.Gilead Sciences, Inc.HELSINNIncyte CorporationIntegra ConnectLillySanofi GenzymeTakeda Oncology

ENDOWMENTSENDOWED YIAs FOR 2016

JANE C. WRIGHT, MD, ENDOWED YOUNG INVESTIGATOR AWARD

Supporting all areas of cancer research

Srinivas Viswanathan, MD, PhD Will explore the potential to selectively target a novel pathway that degrades prematurely terminated mRNA in certain cancers

Supported By

ANNA BRAGLIA ENDOWED YOUNG INVESTIGATOR AWARD

IN CANCER SUPPORTIVE CARE, SUPPORTED BY HELSINNSupporting cancer supportive care

First YIA recipient to be awarded in 2017.

Supported By

ÅKE BERTIL ERIKSSON ENDOWED YOUNG

INVESTIGATOR AWARDSupporting all areas of cancer research

David Kurtz, MD Will investigate the use of serial circulating tumor DNA measurements to determine response to treatment in diffuse large B-cell lymphoma (DLBCL)

Supported By Aaron and Barbro Sasson

ENDOWMENTSENDOWED YIAs FOR 2016

CONQUER CANCER FOUNDATION OF ASCO YOUNG

INVESTIGATOR AWARD IN MEMORY OF SALLY GORDONSupporting all areas of cancer research

Sarah Derks, MD Will detail the immune suppressant mechanisms in esophageal adenocarcinoma and develop approaches that will allow the immune system to attack these cancers

Supported By Anonymous

CONQUER CANCER FOUNDATION

OF ASCO YOUNG INVESTIGATOR AWARD IN MEMORY OF EVELYN H. LAUDERSupporting breast cancer research

Sangeetha Reddy, MD, MSc Will investigate the role of immune system cells in the tumor on the response to chemotherapy

Supported By

CONQUER CANCER FOUNDATION

OF ASCO YOUNG INVESTIGATOR AWARD IN MEMORY OF JOHN R. DURANT, MDSupporting all areas of cancer research

Scott James, MD, PhD Will develop a new way to make CAR T cell therapy significantly safer by reducing or preventing immune attack against healthy tissues

Supported By

CONQUER CANCER FOUNDATION

OF ASCO YOUNG INVESTIGATOR AWARD IN MEMORY OF SALLY GORDONSupporting all areas of cancer research

2016

Lara AnnDunn, MD Studied a novel targeted drugtherapy to treat metastatic radioiodine-refractory thyroid cancers

Benjamin Lok, MDWill evaluate two new potential predictivebiomarkers for PARP inhibitor sensitivityin Small Cell Lung Carcinoma (SCLC)

Supported ByAnonymous

Benjamin Lok, MD Will evaluate two new potential predictive biomarkers for PARP inhibitor sensitivity in Small Cell Lung Carcinoma (SCLC)

Supported By Anonymous

201620162016